HIV and STI Co-Infection: Risks, Synergism, and Prevention Strategies
People with HIV are 2–5 times more likely to acquire other STIs, and STIs increase HIV transmission risk. This bidirectional synergism drives epidemics.
Why HIV Increases STI Susceptibility
- Mucosal barrier disruption: HIV depletes CD4+ T cells in gut-associated lymphoid tissue (GALT) → impaired mucosal immunity.
- Immune activation: Chronic inflammation ↑ target cells (CCR5+) at mucosa.
- Impaired clearance: Reduced ability to clear HPV, HSV, syphilis.
- Shared risk behaviors: Condomless sex, multiple partners, substance use.
Common Co-Infections
| STI | Interaction with HIV | Clinical Impact |
|---|---|---|
| HSV-2 | Ulcers = portal for HIV entry/exit; HIV ↑ HSV reactivation frequency/severity | Severe, persistent ulcers; acyclovir resistance more common |
| HPV | HIV ↓ clearance → persistent infection; ↑ high-risk types | ↑ Cervical/anal dysplasia, cancer; earlier onset |
| Chlamydia / Gonorrhea | Inflammation ↑ HIV shedding in genital tract | Asymptomatic common; ↑ PID, epididymitis; LGV (chlamydia serovars L1-L3) in MSM |
| Syphilis | Genital ulcers ↑ HIV transmission; HIV alters serology (false-neg RPR, prozone), ↑ neurosyphilis risk | Rapid progression; need CSF exam if neuro signs |
| Trichomonas | ↑ HIV shedding in women | Vaginitis; metronidazole resistance emerging |
Prevention Pillars
- ART + Viral Suppression (U=U): Undetectable viral load = effectively zero sexual HIV transmission. Foundation of prevention.
- Condoms: Consistent, correct use ↓ all STIs (not 100% for HPV/HSV).
- PrEP (HIV-negative partners): TDF/FTC or TAF/FTC daily or event-driven (2-1-1).
- DoxyPEP: 200mg doxycycline within 72h post-sex ↓ bacterial STIs (syphilis, chlamydia, gonorrhea) in MSM/TGW (CDC 2024 guideline).
- Vaccines: HPV (9-valent through age 45), Hep A/B, Mpox.
- Regular Screening: Every 3–6 months for sexually active PLWH: NAAT (GC/CT), syphilis serology, HIV VL, HPV (cervical/anal), trichomonas.
- Partner Services: Expedited partner therapy (EPT), notification.
Clinical Pearls
- Treat STIs promptly — reduces HIV infectiousness.
- Syphilis serology interpretation in HIV: use RPR titer + treponemal; consider CSF if RPR ≥1:32, neuro signs, or treatment failure.
- HPV-related cancer screening: earlier, more frequent.
Integrated HIV/STI care improves outcomes for both.
HIV & AIDS - Related Articles
- HIV Transmission Risk from Sewing Needles: Zero Risk
- Supporting People Living with HIV/AIDS: Combating Stigma and Promoting Inclusion
- PCP (Pneumocystis Pneumonia) and HIV: Not Always Linked
- HIV Testing Window Period: Antibody Development Timeline and Diagnostic Implications
- HIV/AIDS in Teens: Risks, Prevention & Education
- Understanding HIV Transmission: Routes, Myths, and Prevention
- Understanding HIV/AIDS Treatment Duration & Initiation
